SCHEMBL5102133

SCHEMBL5102133

CN1CCN(Cc2cc(-c3ccc4c(c3)CCO4)nn(CC3CC3)c2=O)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 2/20 0.37
NTRK1 P04629 1/20 0.37
FLT3 P36888 1/20 0.37
NTRK3 Q16288 1/20 0.37
NTRK2 Q16620 1/20 0.37
CHRNA1 P02708 1/20 0.36
CHRNG P07510 1/20 0.36
CHRNB1 P11230 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA7 P36544 1/20 0.36
CHRNA4 P43681 1/20 0.36
HTR3A P46098 1/20 0.36
CHRND Q07001 1/20 0.36
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
DYRK1A Q13627 1/20 0.35
MAPT P10636 1/20 0.35
MCHR1 Q99705 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5108547 0.90 SMN1; SMN2 (0.35) CYP11B2RAB9ASMN1; SMN2DYRK1AMAPT
SCHEMBL5095043 0.86 GPR119 (0.41) CYP11B2
SCHEMBL5094797 0.84 RAB9A (0.39) CYP11B2RAB9ASMN1; SMN2DYRK1AMAPT
SCHEMBL5098222 0.84 DYRK1A (0.41) RAB9ASMN1; SMN2DYRK1AMAPTPDE4A
SCHEMBL5098172 0.84 GSK3B (0.41) SMN1; SMN2MAPTMCHR1
SCHEMBL5107984 0.84 RAB9A (0.37) CYP11B2RAB9ASMN1; SMN2DYRK1AMAPT
SCHEMBL5095099 0.84 CNR2 (0.43) RAB9AMAPTNPC1CHRM5CXCR3
SCHEMBL5094794 0.83 GSK3B (0.42) SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL5102076 0.83 CNR2 (0.43) RAB9AMAPTNPC1CHRM5CXCR3
SCHEMBL1925632 0.82 HTR6 (0.35) CHRNA7SMN1; SMN2DYRK1AMCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7314877-B2 Benzofuran derivative KOWA CO., LTD. (JP) 2008-01-01 US claimed
US-20060189621-A1 Benzofuran derivative KOWA CO., LTD. (JP) 2006-08-24 US claimed
EP-1602655-A1 BENZOFURAN DERIVATIVE Kowa Co., Ltd. (JP) 2005-12-07 EP claimed
US-7314877-B2 Benzofuran derivative KOWA CO., LTD. (JP) 2008-01-01 US disclosed
US-20060189621-A1 Benzofuran derivative KOWA CO., LTD. (JP) 2006-08-24 US disclosed
EP-1602655-A1 BENZOFURAN DERIVATIVE Kowa Co., Ltd. (JP) 2005-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189621-A1 Benzofuran derivative TNF, TNFRSF1A, RELA CYP11B2 238/4885NTRK1 432/4885FLT3 2016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.